M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.89 USD -1.35% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MoonLake Immunotherapeutics
Cash from Operating Activities Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Cash from Operating Activities
-$42.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Cash from Operating Activities
-$118.7m
CAGR 3-Years
11%
CAGR 5-Years
0%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Cash from Operating Activities
CHf44.6m
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Cash from Operating Activities
-$188.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Cash from Operating Activities
-CHf62m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Cash from Operating Activities
CHf171.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Cash from Operating Activities?
Cash from Operating Activities
-42.8m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Cash from Operating Activities amounts to -42.8m USD.

What is MoonLake Immunotherapeutics's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
23%

Over the last year, the Cash from Operating Activities growth was 23%.

Back to Top